Cue Biopharma (CUE) Depreciation and Depletion (2017 - 2025)

Cue Biopharma has disclosed Depreciation and Depletion across 9 years of filings, most recently posting $65000.0 for Q4 2025.

• Depreciation and Depletion for Q4 2025 came in at $65000.0, down 31.58% year-over-year; the trailing twelve-month figure through Dec 2025 was $335000.0 (down 13.66% YoY), and the FY2025 annual result was $336000.0, down 12.73% from the prior year.
• Depreciation and Depletion came in at $65000.0 for Q4 2025 at Cue Biopharma, down from $76000.0 in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $232000.0 in Q3 2021 to a low of $65000.0 in Q4 2025.
• The 5-year median for Depreciation and Depletion is $122500.0 (2023), against an average of $149055.7.
• Across the five-year window, Depreciation and Depletion advanced 23.08% in 2021 and sank 52.83% in 2023, its largest moves.
• Cue Biopharma's Depreciation and Depletion stood at $227114.0 in 2021, then declined by 11.5% to $201000.0 in 2022, then slipped by 27.86% to $145000.0 in 2023, then plunged by 34.48% to $95000.0 in 2024, then slumped by 31.58% to $65000.0 in 2025.
• The last three Depreciation and Depletion figures came in at $65000.0 (Q4 2025), $76000.0 (Q3 2025), and $97000.0 (Q2 2025), per Business Quant data.